Panic Attacks (Panic Disorder)



Neural Effects of Cognitive-behaviour Therapy in Panic Disorder


Condition:   Panic Disorder
Intervention:   Behavioral: Cognitive Behaviour Therapy
Sponsor:   University of Oxford
Completed


The Association Between Physical Sensations and Thinking Styles


Condition:   Panic Disorder
Intervention:   Behavioral: Cognitive Behaviour Therapy
Sponsors:   Ruhr University of Bochum;   German Research Foundation;   University of Oxford;   University of Salzburg
Recruiting


Different Neural Circuit Mechanisms Between Cognitive Therapy and Behavior Therapy for Patients With Panic Disorder: a Dynamic Research


Condition:   Panic Disorder
Interventions:   Behavioral: Cognitive therapy;   Behavioral: Behavior therapy;   Drug: SSRI antidepressants
Sponsor:   Nanjing Medical University
Recruiting


Virtual Reality for Panic Disorder With Agoraphobia


Condition:   Panic; Agoraphobia
Intervention:   Behavioral: Virtual Reality cognitive behavior therapy
Sponsor:   Karolinska Institutet
Not yet recruiting


Internet-based Exposure Therapy for Panic Disorder


Condition:   Panic Disorder With Agoraphobia
Intervention:   Behavioral: Internet-based cognitive-behavior therapy
Sponsor:   Karolinska Institutet
Completed


The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens


Conditions:   Anxiety;   Panic Disorder
Intervention:   Device: Freespira Breathing System
Sponsors:   Johns Hopkins University;   Palo Alto Health Sciences, Inc.
Recruiting


Trans-diagnostic Group CBT vs. Standard Group CBT for Depression, Social Anxiety and Agoraphobia/Panic Disorder


Conditions:   Depression, Unipolar;   Anxiety Disorder Social;   Panic Disorder
Interventions:   Behavioral: UP-CBT;   Behavioral: Standard-CBT
Sponsors:   Psychiatric Research Unit, Region Zealand, Denmark;   Aarhus University Hospital;   Mental Health Centre Copenhagen;   University of Copenhagen
Enrolling by invitation


Using the Canary Breathing System for Panic Disorder Patients


Condition:   Panic Disorder
Intervention:   Device: Canary Breathing System
Sponsor:   Palo Alto Health Sciences, Inc.
Completed


Cognitive Behavior Therapy vs Exposure in Vivo in the Treatment of Panic Disorder With Agoraphobia


Condition:   Panic Disorder With Agoraphobia
Interventions:   Behavioral: Cognitive behavior therapy;   Behavioral: Exposure in-vivo
Sponsor:   Ruhr University of Bochum
Recruiting


Psychotherapy Outcome and Self-selection Effects in Panic Disorder


Condition:   Panic Disorder (With or Without Agoraphobia)
Interventions:   Behavioral: Panic Control Treatment (PCT);   Behavioral: Panic-Focused Psychodynamic Psychotherapy (PFPP);   Other: Waiting-list
Sponsor:   Region Skane
Active, not recruiting


Escitalopram Trial for Irritable Bowel Syndrome (IBS) Patients With Panic Disorder


Conditions:   Irritable Bowel Syndrome;   Panic Disorder
Intervention:   Drug: Escitalopram
Sponsor:   Maastricht University Medical Center
Completed


Special Drug Use Investigation for PAXIL Tablet (Pediatric Panic Disorder)


Condition:   Panic Disorder
Intervention:   Drug: Paroxetine
Sponsor:   GlaxoSmithKline
Completed


Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)


Condition:   Panic Disorder
Intervention:   Drug: Paroxetine
Sponsor:   GlaxoSmithKline
Completed


Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)


Conditions:   Bipolar Disorder;   Panic Disorder;   Generalized Anxiety Disorder
Interventions:   Drug: Ziprasidone;   Drug: Placebo
Sponsors:   VA Palo Alto Health Care System;   Pfizer;   University of South Florida;   Lindner Center of HOPE
Completed


Treatment of Late-life Anxiety in Primary Care Settings


Conditions:   Generalized Anxiety Disorder;   Panic Disorder;   Anxiety Disorder Not Otherwise Specified
Interventions:   Behavioral: Cognitive behavioral therapy;   Behavioral: Enhanced usual care
Sponsors:   Wake Forest University Health Sciences;   National Institute of Mental Health (NIMH)
Completed


CO2 Inhalation and Risk for Panic Disorder


Condition:   Panic Disorder
Intervention:  
Sponsor:   National Institute of Mental Health (NIMH)
Completed


Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder


Condition:   Panic Disorder
Interventions:   Drug: d-cycloserine;   Drug: placebo
Sponsors:   Boston University;   National Institute on Drug Abuse (NIDA);   National Institute of Mental Health (NIMH)
Unknown status


Cognitive Behavioral Therapy in Panic Disorder


Condition:   Panic Disorder
Intervention:  
Sponsor:   Universidade Federal do Rio de Janeiro
Completed


Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)


Condition:   Panic Disorder
Interventions:   Behavioral: Cognitive-behavioral therapy;   Drug: Org 25935;   Drug: Placebo
Sponsor:   Merck Sharp & Dohme Corp.
Terminated


Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD


Conditions:   Bipolar Disorder;   Panic Disorder;   Generalized Anxiety Disorder
Interventions:   Drug: quetiapine SR;   Drug: divalproex sodium ER;   Drug: placebo
Sponsors:   University of South Florida;   AstraZeneca
Unknown status


Staccato Alprazolam in Panic Attack


Condition:   Treatment of Induced Panic Attack
Interventions:   Drug: Inhaled placebo;   Drug: Inhaled alprazolam 1 mg;   Drug: Inhaled alprazolam 2 mg;   Drug: IV doxapram
Sponsor:   Alexza Pharmaceuticals, Inc.
Completed


Neurobiological Mechanisms in Panic Disorder


Condition:   Panic Disorder
Intervention:  
Sponsor:   National Institute of Mental Health (NIMH)
Completed


Evaluation of Substance P Neurotransmission in Panic Disorder by PET Imaging of NK1 Receptors With [18F]SPA-RQ


Conditions:   Panic Disorder;   Healthy
Intervention:   Drug: [18F] SPA-RQ
Sponsor:   National Institute of Mental Health (NIMH)
Completed


Genetic Causes of Panic Disorder


Condition:   Panic Disorder
Intervention:  
Sponsor:   National Institute of Mental Health (NIMH)
Completed


Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder


Conditions:   Panic Disorder;   Posttraumatic Stress Disorder;   Major Depressive Disorder
Intervention:  
Sponsor:   National Institute of Mental Health (NIMH)
Completed

Refine Your Search Advanced Search